Here’s what you should know.
1. The institute will be the first of its kind in New York City.
2. Mount Sinai is viewing it as a way to expand its eye and vision research portfolio.
3. The institute will encourage collaboration between faculty at the Icahn School of Medicine at Mount Sinai and the academic departments throughout the Mount Sinai Health System.
4. Mount Sinai tapped Douglas A. Jabs, MD, to be the center’s inaugural director.
More articles on transactions/valuations:
Surgical Care Affiliates, OptumCare to merge; Nobilis Health Corp. to boost in-network patient volume by 50%+ through Hamilton Vein Center deal & more — 6 ASC company key notes
Vero Orthopaedics & Neurology adds ASC: 4 key notes
Royal Bank of Canada increases AmSurg price target to $87 — 5 facts
